- Home
- DUO vs CLRB Comparison
DUO vs CLRB Comparison
Compare DUO & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DUO
- CLRB
- Stock Information
- Founded
- DUO 2011
- CLRB 2002
- Country
- DUO China
- CLRB United States
- Employees
- DUO N/A
- CLRB N/A
- Industry
- DUO Real Estate
- CLRB Biotechnology: Pharmaceutical Preparations
- Sector
- DUO Finance
- CLRB Health Care
- Exchange
- DUO Nasdaq
- CLRB Nasdaq
- Market Cap
- DUO 11.4M
- CLRB 12.5M
- IPO Year
- DUO 2019
- CLRB N/A
- Fundamental
- Price
- DUO $0.20
- CLRB $0.36
- Analyst Decision
- DUO
- CLRB Hold
- Analyst Count
- DUO 0
- CLRB 2
- Target Price
- DUO N/A
- CLRB N/A
- AVG Volume (30 Days)
- DUO 8.9M
- CLRB 34.3M
- Earning Date
- DUO 06-13-2025
- CLRB 05-13-2025
- Dividend Yield
- DUO N/A
- CLRB N/A
- EPS Growth
- DUO N/A
- CLRB N/A
- EPS
- DUO 0.47
- CLRB N/A
- Revenue
- DUO $46,458,330.00
- CLRB N/A
- Revenue This Year
- DUO N/A
- CLRB N/A
- Revenue Next Year
- DUO N/A
- CLRB N/A
- P/E Ratio
- DUO $0.40
- CLRB N/A
- Revenue Growth
- DUO 19.00
- CLRB N/A
- 52 Week Low
- DUO $0.19
- CLRB $0.22
- 52 Week High
- DUO $4.67
- CLRB $3.42
- Technical
- Relative Strength Index (RSI)
- DUO 37.29
- CLRB 61.13
- Support Level
- DUO $0.19
- CLRB $0.23
- Resistance Level
- DUO $0.21
- CLRB $0.69
- Average True Range (ATR)
- DUO 0.01
- CLRB 0.05
- MACD
- DUO -0.00
- CLRB 0.02
- Stochastic Oscillator
- DUO 23.73
- CLRB 26.84
About DUO Fangdd Network Group Ltd.
Fangdd Network Group Ltd is an investment holding company. It is engaged in the provision of real estate information services through its online platform which also offers integrated marketing services for individual customers, real estate developers, and agents in China. Its SaaS-based solutions help real estate agents to connect with essential business resources, including customers, property listings, capital, and transaction data. The company generates the majority of its revenue from Base commission from transactions in China.
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.